Dendrite Imaging, Inc., the world’s exclusive developer of a surgical nerve imaging system, today announces the appointment of Ali Amiri as Chief Executive Officer (CEO), Dr. Raul Rosenthal as President, and Dr. Fernando Dip as Chief Medical Officer (CMO). This strategic leadership transition is designed to leverage Amiri’s extensive experience in medical device commercialization.

“We are thrilled that Ali Amiri has agreed to become Dendrite’s CEO at this pivotal juncture” said Dr. Rosenthal. “His three decades of leadership in the medical device industry, including key roles at KARL STORZ Endoscopy and UroViu Corporation, make him uniquely suited to guide our pursuit of regulatory clearance and product commercialization.” Co-founders Dr. Rosenthal and Dr. Dip will remain focused on forging strategic partnerships, as well as research and development to maximize clinical safety and efficacy.

“Intraoperative nerve injury can lead to debilitating complications. Dendrite Imaging's near ultraviolet visualization potential to assist surgeons in preserving or restoring crucial sensory functions is extraordinary” said Ali Amiri. “I am honored to lead the company as we prepare for transitioning from research & development to commercialization, bringing this revolutionary technology to surgeons and patients worldwide.”